Loading...
Docoh

Daxor (DXR)

Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation (organized as an investment company with fully-owned innovative medical instrumentation and biotechnology operations). Daxor Corporation developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. The BVA technology enhances hospital performance metrics in a broad range of surgical and medical conditions, including heart failure and critical care, by informing treatment strategies, resulting in significantly improved multiple measures of patient outcomes. Daxor's mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor's vision is optimal blood volume for all.

Company profile

DXR stock data

Funds

Data from SEC filings
Series Ticker %Monthly Return ? $Assets #Holdings As of
None 0 0 0 16.51M 25 Sep 2021

Calendar

2 May 22
19 Aug 22
31 Dec 22
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
23 Jun 22 Caleb DesRosiers Stock options Common Stock Grant Acquire A No No 13.09 4,000 52.36K 4,000
23 Jun 22 Edward Feuer Stock Options COMMON STOCK Grant Acquire A No No 13.09 2,000 26.18K 2,000
23 Jun 22 Joy S. Goudie STOCK OPTIONS COMMON STOCK Grant Acquire A No No 13.09 2,000 26.18K 2,000
23 Jun 22 Henry D. Cremisi STOCK OPTION COMMON STOCK Grant Acquire A No No 13.09 2,000 26.18K 2,000
23 Jun 22 James A Lombard STOCK OPTION COMMON STOCK Grant Acquire A No No 13.09 2,000 26.18K 2,000
1.8% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 5 1 +400.0%
Opened positions 4 0 NEW
Closed positions 0 5 EXIT
Increased positions 1 0 NEW
Reduced positions 0 1 EXIT
13F shares Current Prev Q Change
Total value 755K 246K +206.9%
Total shares 70.83K 21.82K +224.6%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Vanguard 47.33K $504K NEW
Renaissance Technologies 22.42K $239K +2.7%
UBS UBS Group AG - Registered Shares 855 $9K NEW
MS Morgan Stanley 175 $2K NEW
Tower Research Capital 52 $1K NEW
Proequities 0 $0
Largest transactions Shares Bought/sold Change
Vanguard 47.33K +47.33K NEW
UBS UBS Group AG - Registered Shares 855 +855 NEW
Renaissance Technologies 22.42K +600 +2.7%
MS Morgan Stanley 175 +175 NEW
Tower Research Capital 52 +52 NEW
Proequities 0 0